BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2021 Results Conference Call February 23, 2022 8:30 AM ET Company Participants John Bluth - SVP, IR and Corporate Communications Jon Stonehouse - Chief Executive Officer Anthony Doyle - Chief Financial Officer Charlie Gayer - Chief Commercial Officer Dr. Helen Thackray - Chief R&D Officer Conference Call Participants Ken Cacciatore - Cowen and Company Tazeen Ahmad - Bank of America Jessica Fye - JPMorgan Chris Raymond - Piper Sandler Liisa Bayko - Evercore ISI ...